FDA Inspection
SightlifeSightlife – FDA Inspection, Dec 17, 2012
Record Details
This FDA Inspection record concerns Sightlife, with an inspection on December 17, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Sightlife
- Inspection Date
- December 17, 2012
- Product Type
- Biologics
View Company Profile
ID · 34ae8cd2-dd58-4172-805b-5477604dc6fb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 811110
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.200(a)Cleaned, sanitized per established schedules
- 21 CFR 1271.180(c)Availability of procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sightlife
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2026 | Not classified | Seattle District Office | |
| November 18, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 10, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| October 13, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 14, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Sightlife
- FDA Inspection 1318978 - 2026-04-30
- FDA Inspection 1254770 - 2024-11-18
- FDA Inspection 1198187 - 2023-02-10
- FDA Inspection 1028861 - 2017-10-13
- FDA Inspection 963070 - 2016-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.